These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23295770)
1. Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization. Steinmetz M; Pelster B; Lucanus E; Arnal JF; Nickenig G; Werner N J Mol Cell Cardiol; 2013 Apr; 57():32-42. PubMed ID: 23295770 [TBL] [Abstract][Full Text] [Related]
2. Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization. Fontaine V; Filipe C; Werner N; Gourdy P; Billon A; Garmy-Susini B; Brouchet L; Bayard F; Prats H; Doetschman T; Nickenig G; Arnal JF Am J Pathol; 2006 Nov; 169(5):1855-62. PubMed ID: 17071606 [TBL] [Abstract][Full Text] [Related]
3. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Iwakura A; Luedemann C; Shastry S; Hanley A; Kearney M; Aikawa R; Isner JM; Asahara T; Losordo DW Circulation; 2003 Dec; 108(25):3115-21. PubMed ID: 14676142 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Goukassian DA; Qin G; Dolan C; Murayama T; Silver M; Curry C; Eaton E; Luedemann C; Ma H; Asahara T; Zak V; Mehta S; Burg A; Thorne T; Kishore R; Losordo DW Circulation; 2007 Feb; 115(6):752-62. PubMed ID: 17261656 [TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. Tsubaki M; Satou T; Itoh T; Imano M; Yanae M; Kato C; Takagoshi R; Komai M; Nishida S Mol Cell Endocrinol; 2012 Sep; 361(1-2):219-31. PubMed ID: 22579611 [TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Assmus B; Urbich C; Aicher A; Hofmann WK; Haendeler J; Rössig L; Spyridopoulos I; Zeiher AM; Dimmeler S Circ Res; 2003 May; 92(9):1049-55. PubMed ID: 12676819 [TBL] [Abstract][Full Text] [Related]
7. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts. Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630 [TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066 [TBL] [Abstract][Full Text] [Related]
9. A novel role for receptor activator of nuclear factor (NF)-κβ ligand (RANKL) in atorvastatin-mediated mobilization of endothelial progenitor cells. Endo J; Sano M J Mol Cell Cardiol; 2013 Jun; 59():148-50. PubMed ID: 23458362 [No Abstract] [Full Text] [Related]
10. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092 [TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats. Wang B; Sun L; Tian Y; Li Z; Wei H; Wang D; Yang Z; Chen J; Zhang J; Jiang R J Neurol Sci; 2012 Aug; 319(1-2):117-23. PubMed ID: 22658532 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis. Rattazzi M; Faggin E; Buso R; Di Virgilio R; Puato M; Plebani M; Zaninotto M; Palmosi T; Bertacco E; Fadini GP; Pauletto P Cardiovasc Ther; 2016 Feb; 34(1):13-20. PubMed ID: 26506085 [TBL] [Abstract][Full Text] [Related]
14. Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment. Arai A; Mizoguchi T; Harada S; Kobayashi Y; Nakamichi Y; Yasuda H; Penninger JM; Yamada K; Udagawa N; Takahashi N J Cell Sci; 2012 Jun; 125(Pt 12):2910-7. PubMed ID: 22454522 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow AT1 augments neointima formation by promoting mobilization of smooth muscle progenitors via platelet-derived SDF-1{alpha}. Yokoi H; Yamada H; Tsubakimoto Y; Takata H; Kawahito H; Kishida S; Kato T; Matsui A; Hirai H; Ashihara E; Maekawa T; Iwai M; Horiuchi M; Ikeda K; Takahashi T; Okigaki M; Matsubara H Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):60-7. PubMed ID: 19834109 [TBL] [Abstract][Full Text] [Related]
17. IL-1 plays an important role in the bone metabolism under physiological conditions. Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667 [TBL] [Abstract][Full Text] [Related]
19. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process. Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895 [TBL] [Abstract][Full Text] [Related]